KORU Medical Systems Q2 2024 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $8.430M Beat $7.570M Estimate
KORU Medical Systems Q2 2024 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $8.430M Beat $7.570M Estimate
2024年第二季度KORU医疗系统每股收益调整后为$(0.01)，超过$(0.04)的预期，销售额为$8.43百万，超过$7.57百万的预期。
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $8.430 million which beat the analyst consensus estimate of $7.570 million by 11.36 percent. This is a 21.54 percent increase over sales of $6.936 million the same period last year.
KORU Medical Systems（纳斯达克股票代码：KRMD）公布的季度亏损为每股0.01美元，比分析师普遍预期的0.04美元（0.04美元）高出75％。这比去年同期每股亏损0.04美元（0.04）增长了75％。该公司公布的季度销售额为84.3亿美元，比分析师普遍预期的757.0万美元高出11.36％。这比去年同期的693.6万美元的销售额增长了21.54％。